WVEWave Life Sciences Ltd.
5.290USDMkt Cap: 1.04B $P/E: —3d ago
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap1.04B $
Enterprise Value587.49M $
Revenue (TTM)65.37M $
Gross Profit-132.05M $
Net Income (TTM)-204.38M $
Revenue/Share0.3480 USD
Last Price5.290 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees317
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINSG9999014716
Valuation
P/E (Trailing)—
P/E (Forward)-4.41
PEG—
EV/EBITDA-2.74
EV/Revenue8.99
P/S15.83
P/B1.90
EPS (TTM)-1.05
EPS (Forward)-1.19
52W Range
5.26512% of range5.475
52W High5.475 USD
52W Low5.265 USD
Profitability
Gross Margin-202.00%
Oper. Margin-3248.33%
EBITDA Margin0.00%
Profit Margin-478.33%
ROE-39.43%
ROA-32.01%
Growth
Revenue Growth-73.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-187.49M $
CapEx (TTM)718.00K $
FCF Margin-197.00%
FCF Yield-12.35%
Net Debt-447.01M $
Net Debt/EBITDA2.08
Balance Sheet
Debt/Equity0.03
Current Ratio9.99
Quick Ratio9.67
Book Value/Sh2.762 USD
Cash/Share2.490 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)19.06 USD
Upside (mean)+260.3%
Target Range12.00 USD – 42.00 USD
$12.00+260.3% to mean$42.00
# Analysts16
Ownership
Shares Out.197.05M
Float94.57M
Insiders15.50%
Institutions85.61%
Short Interest
Short Ratio6.6d
Short % Float10.27%
Short % Out.8.32%
Shares Short16.40M
Short (prev mo.)20.90M
Technical
SMA 505.832 (-9.3%)
SMA 2009.462 (-44.1%)
Beta-1.29
S&P 52W Chg21.00%
Avg Vol (30d)2.70M
Avg Vol (10d)3.94M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—